Thomas Mark

Partner

New York
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
T 212 728 8667
F 212 728 9667
tmarkwillkie.com

Thomas Mark is a partner in the Corporate & Financial Services Department and focuses on mergers and acquisitions, securities offerings, private equity and general corporate and securities law.

Highlights

Thomas Mark is a partner in the Corporate & Financial Services Department and focuses on mergers and acquisitions, securities offerings, private equity and general corporate and securities law.

Selected Significant Matters

Thomas has advised on significant M&A, investment and offering related matters for the following clients:

MERGERS & ACQUISITIONS

  • Insight Venture Partners in its acquisition of Diligent, a take-private transaction valued at approximately $624 million
  • Syncsort in its acquisition by Clearlake Capital Group
  • Valtech Cardio in its proposed acquisition by HeartWare International
  • Time Warner and Turner Broadcasting, Inc. in Turner Broadcasting’s acquisition of iStreamPlanet
  • HealthcareSource in its sale to Francisco Partners
  • Colony Financial, Inc. in its acquisition of Cobalt Capital Partners and its highly diversified portfolio of 256 primarily light industrial assets
  • Santa Barbara Tax Products Group in its sale to Green Dot Corporation
  • iParadigms in its sale to Insight Venture Partners and GIC, Singapore's sovereign wealth fund, from majority owner Warburg Pincus
  • JHP Pharmaceuticals and Warburg Pincus in Warburg Pincus’ sale of JHP to Par Pharmaceutical
  • OnTargetJobs in its sale to Dice Holdings
  • Clovis Oncology in its acquisition of EOS (Ethical Oncology Science) S.p.A.
  • Scotsman Industries and Warburg Pincus in the sale of Scotsman to the ALI Group
  • ITC Nexus in its acquisition of Accumetrics
  • CAI in its acquisition of PCS-CTS
  • GHX Industrial in its sale to United Central Industrial Supply
  • RG Steel in the sale of substantially all of its assets in bankruptcy
  • Turner Broadcasting System in its acquisition of Bleacher Report
  • Telcordia Technologies, Providence Equity Partners and Warburg Pincus in the sale of Telcordia to Ericsson
  • Level 3 Communications in its acquisitions of TelCove and Telverse Communications
  • The joint venture of América Móvil and Teléfonos de Mexico in the venture’s proposed acquisition of Verizon’s interest in CANTV
  • 3i in its acquisition of Hilite International
  • Teléfonos de Mexico in the sale of its equity interest in MCI to Verizon
  • Globe Specialty Metals in its sale of its Brazilian operations to Dow Corning and the establishment of a joint venture with Dow Corning at Globe’s West Virginia silicon metal facility
  • Pharmion Corporation in connection with its acquisition of Cabrellis Pharmaceuticals; and its sale to Celgene Corporation
  • Deutsche Bank as financial advisors in the merger of Ticketmaster and Live Nation
  • Merrill Lynch as financial advisor to Dubai International Capital in connection with its investment in Och-Zifff Capital Management
  • eToys in its acquisition of BabyUniverse
  • Brookfield Asset Management in its cornerstone investment in General Growth Properties and its subsequent acquisition of an additional ownership interest in General Growth Properties
  • Stiefel Laboratories in connection with its acquisitions of Connetics Corporation and Barrier Therapeutics; and in its sale to GlaxoSmithKline
  • Warburg Pincus in connection with its acquisition of Scotsman Industries
  • Lehman Brothers in connection with its acquisition of Robeco Investment Management
  • Adelphia Communications in connection with its bankruptcy restructuring
  • Hampshire Group in connection with its sale of its Shane Hunter division

SECURITIES OFFERINGS

  • Clovis Oncology in its initial public offering and its subsequent follow-on and secondary offerings of common stock in 2012, 2013 and 2015, and 144A offering of convertible senior notes
  • Pharmion Corporation in its initial public offering and subsequent follow-on offerings of common stock
  • American Campus Communities in its initial public offering of common stock
  • Level 3 Communications in its various public offerings of common stock, senior notes and senior convertible notes
  • Teva Pharmaceuticals in various public offerings of senior notes and senior convertible debentures
  • Telcordia Technologies in its Rule 144A offering of senior notes
  • Martin Marietta Materials in its public offering of senior notes
  • The underwriters in Synageva’s public offering of its common stock
  • The underwriters in Strategic Hotels’ public offering of its common stock
  • The underwriters in Inspire Pharmaceutical’s various public offerings of common stock
  • The underwriters in Lennar’s various public and Rule 144A offerings of senior notes
  • The initial purchasers in LNR Property’s various Rule 144A offerings of senior convertible notes
  • Converium in connection with its rights offering

PRIVATE EQUITY

  • Time Warner in its equity investments in Central European Media Enterprises (CME) in 2013, 2012, 2011 and 2009, and with CME’s rights offering and related financing transactions in 2014
  • Stiefel Laboratories in connection with Blackstone’s equity investment in Stiefel
  • Warburg Pincus in connection with its equity investment in Cortview Capital
  • Clovis Oncology in connection with multiple rounds of equity and debt financing by venture capital firms and Pfizer
  • Soros Fund Management in connection with its equity investment in Salt Creek Hospitality
  • A family office in connection with a number of private equity investments